会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Process for the manufacture of tocyl and tocopheryl acylates
    • 制备辛酰基和生育酚酰化物的方法
    • US20060293529A1
    • 2006-12-28
    • US10554885
    • 2004-04-27
    • Werner BonrathLisa Giraudi
    • Werner BonrathLisa Giraudi
    • C07D311/02
    • C07D311/72
    • A process for the manufacture of a tocyl acylate or a tocopheryl acylate comprises reacting tocol or a tocopherol with an acylating agent in the presence of a solid heterogeneous Brönsted acid catalyst, said catalyst being an inorganic Brönsted acid on a solid carrier material which comprises silicon dioxide, titanium dioxide or both silicon dioxide and titanium dioxide, or being an organofunctional polysilonaxe featuring sulpho groups, the solid heterogeneous Brönsted acid catalyst further featuring a BET surface area from about 10 m2/g to about 800 m2/g and a pore volume from about 0.1 ml/g to about 2.0 ml/g. The main commercial form of vitamin E, being (all-rac)-α-tocopheryl acetate, can be manufactured by acylation of (all-rac)-α-tocopherol according to this process.
    • 制备酰基酰化物或生育酚酰基化物的方法包括在固体异质布朗斯台德酸催化剂存在下,将酰基转化成醇或生育酚,所述催化剂是固体载体材料上的无机布朗斯台德酸,其包含二氧化硅 ,二氧化钛或二氧化硅二氧化钛,或者是具有硫酸基的有机官能聚异氰酸酯,该固体异质布朗斯台德酸催化剂还具有约10m 2 / g至约800μm的BET表面积 2 / g,孔体积为约0.1ml / g至约2.0ml / g。 维生素E的主要商业形式是(全脱氧)-α-生育酚乙酸酯,可以通过根据该方法酰化(全 - 外消旋)-α-生育酚来制备。
    • 3. 发明授权
    • Process for the manufacture of α-tocopheryl acetate
    • 制备α-生育酚乙酸酯的方法
    • US07135580B2
    • 2006-11-14
    • US10541360
    • 2003-12-22
    • Werner BonrathClaus DittelLisa GiraudiThomas NetscherThomas Pabst
    • Werner BonrathClaus DittelLisa GiraudiThomas NetscherThomas Pabst
    • C07D311/72
    • C07D311/72
    • The present invention is concerned with a novel process for the manufacture of α-tocopheryl acetate which comprises reacting 2,3,6-trimethylhydroquinone-1-acetate with a compound selected from the group consisting of phytol (formula IV with R═OH), iso-phytol (formula III with R═OH), and (iso) phytol derivatives represented by the following formulae III and IV with R═C2-to C5-alkonoyloxy, benzoyloxy, mesyloxy, bezenesul-fonyloxy or tosyloxy, (IV) in the presence of a catalyst of the formula Mn+(R1SO3−)n, wherein Mn+ is a silver, copper, gallium, hafnium or rare earth metal cation, n is the valence of the cation Mn+, and R1 is fluorine, C1-8-perfluoroalkyl or perfluoroaryl, and, if required, cyclizing any 3-phytyl-2,5,6-trimethylhydroquinone-1-acetate or a double bond isomer thereof obtained as an intermediate reaction product, to produce α-tocopheryl acetate. In the catalyst Mn+ is preferably Ag+, Cu+, Ga3+, Sc3+, Lu3+, Ho3+, Tm3+, Yb3+ or Hf4+.
    • 本发明涉及制备乙酸α-生育酚酯的新方法,其包括使2,3,6-三甲基氢醌-1-乙酸酯与选自植醇(式IV与R-OH)的化合物反应, 异山嵛醇(具有R-OH的式III)和由下式III和IV表示的(iso)植醇醇衍生物,其具有至少2个至5个C 5 - 烷酰氧基, 苯甲酰氧基,甲磺酰氧基,枯烯二烯基氧基或甲苯磺酰氧基,(Ⅳ)在式M n n n a a a>>>>>>>>>>>>>>>>>>>>>>>>>> 其中M + N +是银,铜,镓,铪或稀土金属阳离子,n是阳离子的化合价 M + N +,R 1是氟,C 1-8 - 全氟烷基或全氟芳基,如果需要,可以将任何3-植酰基 - 获得的作为中间体反应产物的2,5,6-三甲基氢醌-1-乙酸酯或其双键异构体,以产生乙酸α-生育酚酯。 在催化剂中,N + +优选为Ag +,Cu +,Ga 3+,Sc 3 或+ 3+,3+,3 +,3 +,3 +,3 + Hf 4+。
    • 6. 发明授权
    • Process for the manufacture of tocyl and tocopheryl acylates
    • 制备辛酰基和生育酚酰化物的方法
    • US07321053B2
    • 2008-01-22
    • US10554885
    • 2004-04-27
    • Werner BonrathLisa Giraudi
    • Werner BonrathLisa Giraudi
    • C07C67/02
    • C07D311/72
    • A process for the manufacture of a tocyl acylate or a tocopheryl acylate comprises reacting tocol or a tocopherol with an acylating agent in the presence of a solid heterogeneous Brönsted acid catalyst, said catalyst being an inorganic Brönsted acid on a solid carrier material which comprises silicon dioxide, titanium dioxide or both silicon dioxide and titanium dioxide, or being an organofunctional polysilonaxe featuring sulpho groups, the solid heterogeneous Brönsted acid catalyst further featuring a BET surface area from about 10 m2/g to about 800 m2/g and a pore volume from about 0.1 ml/g to about 2.0 ml/g. The main commercial form of vitamin E, being (all-rac)-α-tocopheryl acetate, can be manufactured by acylation of (all-rac)-α-tocopherol according to this process.
    • 制备酰基酰化物或生育酚酰基化物的方法包括在固体异质布朗斯台德酸催化剂存在下,将酰基转化成醇或生育酚,所述催化剂是固体载体材料上的无机布朗斯台德酸,其包含二氧化硅 ,二氧化钛或二氧化硅二氧化钛,或者是具有硫酸基的有机官能聚异氰酸酯,该固体异质布朗斯台德酸催化剂还具有约10m 2 / g至约800μm的BET表面积 2 / g,孔体积为约0.1ml / g至约2.0ml / g。 维生素E的主要商业形式是(全脱氧)-α-生育酚乙酸酯,可以通过根据该方法酰化(全 - 外消旋)-α-生育酚来制备。
    • 7. 发明授权
    • Manufacture of tocol, tocol derivatives and tocopherols
    • tocol,tocol衍生物和生育酚的制造
    • US07105686B2
    • 2006-09-12
    • US10916274
    • 2004-08-11
    • Lisa GiraudiWerner Bonrath
    • Lisa GiraudiWerner Bonrath
    • C07D311/72
    • C07D311/72
    • The present invention is concerned with a novel process for the manufacture of tocol, tocol derivatives and tocopherols, especially α-tocopherol, by the reaction of a hydroquinone featuring 0 to 3 methyl groups, especially 2,3,5-trimethylhydroquinone, with isophytol, phytol or a(n) (iso)phytol derivative, most preferably with isophytol, in the presence of gadolinium trifluoromethanesulfonate, Gd(OSO2CF3)3, as the catalyst in a biphasic solvent system. This biphasic solvent system consists essentially of a polar organic solvent and a non-polar organic solvent. The polar organic solvent is preferably ethylene carbonate and/or propylene carbonate. The non-polar solvent is preferably at least a solvent selected from the group consisting of hexane, heptane, octane, cyclohexane and methylcyclohexane.
    • 本发明涉及通过具有0至3个甲基,特别是2,3,5-三甲基对苯二酚的氢醌与异麦芽糖醇的反应制备托卡因,多肽衍生物和生育酚,特别是α-生育酚的新方法, phytol或(n)(iso)phytol衍生物,最优选与异麦芽糖醇混合,在三氟甲磺酸钆存在下,Gd(OSO 2 CF 3)3 / SUB>作为双相溶剂体系中的催化剂。 该双相溶剂系统基本上由极性有机溶剂和非极性有机溶剂组成。 极性有机溶剂优选为碳酸亚乙酯和/或碳酸亚丙酯。 非极性溶剂优选为选自己烷,庚烷,辛烷,环己烷和甲基环己烷中的至少一种溶剂。
    • 8. 发明申请
    • Manufacture of tocol, tocol derivatives and tocopherols
    • tocol,tocol衍生物和生育酚的制造
    • US20050038269A1
    • 2005-02-17
    • US10916274
    • 2004-08-11
    • Lisa GiraudiWerner Bonrath
    • Lisa GiraudiWerner Bonrath
    • C07D311/72C07D311/74
    • C07D311/72
    • The present invention is concerned with a novel process for the manufacture of tocol, tocol derivatives and tocopherols, especially α-tocopherol, by the reaction of a hydroquinone featuring 0 to 3 methyl groups, especially 2,3,5-trimethylhydroquinone, with isophytol, phytol or a(n) (iso)phytol derivative, most preferably with isophytol, in the presence of gadolinium trifluoromethanesulfonate, Gd(OSO2CF3)3, as the catalyst in a biphasic solvent system. This biphasic solvent system consists essentially of a polar organic solvent and a non-polar organic solvent. The polar organic solvent is preferably ethylene carbonate and/or propylene carbonate. The non-polar solvent is preferably at least a solvent selected from the group consisting of hexane, heptane, octane, cyclohexane and methylcyclohexane.
    • 本发明涉及通过具有0至3个甲基,特别是2,3,5-三甲基对苯二酚的氢醌与异麦芽糖醇的反应制备托卡因,多肽衍生物和生育酚,特别是α-生育酚的新方法, phytol或(n)(iso)phytol衍生物,最优选与异麦芽糖醇混合,在三氟甲磺酸钆存在下,Gd(OSO 2 CF 3)3作为双相溶剂体系中的催化剂。 该双相溶剂系统基本上由极性有机溶剂和非极性有机溶剂组成。 极性有机溶剂优选为碳酸亚乙酯和/或碳酸亚丙酯。 非极性溶剂优选为选自己烷,庚烷,辛烷,环己烷和甲基环己烷中的至少一种溶剂。